|
2026 Journal Article Highlights of 2025: advancements in natural killer cell biologyAires-Lopes, Beatriz and Souza-Fonseca-Guimaraes, Fernando (2026). Highlights of 2025: advancements in natural killer cell biology. Immunology and Cell Biology imcb.70121. doi: 10.1111/imcb.70121 |
|
2026 Journal Article The GFI1-FOXO1 axis regulates NK cell maturation and functionHuang, Qiutong, Chaudhry, M. Zeeshan, Dight, James, Alim, Louisa, Yu, Huiyang, Denman, Renae, Man, Hiu On, Schreuder, Jaring, Garnham, Alexandra L., Tuong, Zewen K., Souza-Fonseca-Guimaraes, Fernando, Jacquelot, Nicolas and Belz, Gabrielle T. (2026). The GFI1-FOXO1 axis regulates NK cell maturation and function. Nature Communications. doi: 10.1038/s41467-026-72022-6 |
|
2026 Journal Article CAR-NK cell-based therapies: translational and regulatory breakthroughsBiggi, Alison Felipe Bordini and Souza-Fonseca-Guimaraes, Fernando (2026). CAR-NK cell-based therapies: translational and regulatory breakthroughs. Immunology and Cell Biology imcb.70120. doi: 10.1111/imcb.70120 |
|
2026 Journal Article Gain‐of‐function enhancers optimize CAR ‐ NK cell‐based anti‐cancer immunotherapyWong, Emma and Souza‐Fonseca‐Guimaraes, Fernando (2026). Gain‐of‐function enhancers optimize CAR ‐ NK cell‐based anti‐cancer immunotherapy. Immunology and Cell Biology imcb.70113. doi: 10.1111/imcb.70113 |
|
2026 Journal Article Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumorsTu, Cui, Tan, Chin Wee, Monkman, James, Almeida, Ana Clara, Antonio-Carreon, Gabrielle, Omer, Natacha, Hull, Giaan, Chung, Kimberly, Mehdi, Ahmed M., Salerno, Antonietta, Vittorio, Orazio, Mayer, Aaron, Machado-Souza, Cleber, Jayabalan, Nanthini, Toh, Yi-Chin, Hon, Hui Nee, de Almeida Brehm Pinhatti, Fernanda, Elifio-Esposito, Selene, Nicholls, Wayne, de Noronha, Lucia, Kulasinghe, Arutha and Souza-Fonseca-Guimaraes, Fernando (2026). Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumors. Genome Medicine, 18 (1) 35. doi: 10.1186/s13073-026-01622-0 |
|
2026 Journal Article Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapyWong, Joshua K. M., Lam, Pui Yeng, Coleborn, Elaina, Alim, Louisa, Jose, Jiya, Tu, Cui, Antczak, Magdalena, Dietmair, Bettina, Hagh, Arghavan Golbaz, Noronha, Lucia, Cheetham, Seth W., Hooper, John, Beavis, Paul A., Merino, Delphine, Berthelet, Jean, Aoude, Lauren G., McCart-Reed, Amy E., Lakhani, Sunil, Simpson, Peter T., Rossi, Gustavo R., Brooks, Andrew J., Jones, Martina L., Simpson, Fiona and Souza-Fonseca-Guimaraes, Fernando (2026). Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy. Molecular Therapy, 34 (3), 1382-1398. doi: 10.1016/j.ymthe.2025.11.021 |
|
2026 Journal Article SM3DD with segmented PCA: a comprehensive method for interpreting 3D spatial transcriptomicsBlick, Tony, Kilgallon, Aaron, Monkman, James, Cooper, Caroline, Tan, Chin Wee, Killingbeck, Emily E., Pan, Liuliu, Kim, Youngmi, Liang, Yan, Nam, Andy, Leon, Michael, Guimaraes, Paulo S. F., Nagashima, Seigo, Martins, Ana P. C., Machado-Souza, Cleber, de Noronha, Lucia, Fraser, John F., Belz, Gabrielle T., Souza-Fonseca-Guimaraes, Fernando and Kulasinghe, Arutha (2026). SM3DD with segmented PCA: a comprehensive method for interpreting 3D spatial transcriptomics. NAR Genomics and Bioinformatics, 8 (1) lqag007, 1-10. doi: 10.1093/nargab/lqag007 |
|
2026 Journal Article Cytokine routing as an overlooked determinant of immune mobilizationZhou, Jingchen and Souza‐Fonseca‐Guimaraes, Fernando (2026). Cytokine routing as an overlooked determinant of immune mobilization. Immunology and Cell Biology, 104 (1) imcb.70069, 70-73. doi: 10.1111/imcb.70069 |
|
2025 Journal Article Coordinated development of immune cell populations in vascularized skin organoids from human induced pluripotent stem cellsMostina, Mitchell, Sun, Jane, Sim, Seen Ling, Ahmed, Imaan A., Souza-Fonesca-Guimaraes, Fernando, Wolvetang, Ernst J., Brown, Jason, Kumari, Snehlata, Khosrotehrani, Kiarash and Shafiee, Abbas (2025). Coordinated development of immune cell populations in vascularized skin organoids from human induced pluripotent stem cells. Advanced Healthcare Materials, 14 (31) e02108, 1-18. doi: 10.1002/adhm.202502108 |
|
2025 Journal Article Facilitating consumer partnerships in health researchGhebosu, Raluca, Young, Leonie, Watson, Benedette, Williams, Merran, Dedmon, Ashley, Maxwell, Jo, Thompson, Erik W., Souza-Fonseca-Guimaraes, Fernando and Wolfram, Joy (2025). Facilitating consumer partnerships in health research. Journal of Translational Medicine, 23 (1) 990, 1-11. doi: 10.1186/s12967-025-07035-8 |
|
2025 Journal Article Antitumor activity of violacein in osteosarcoma, neuroblastoma and triple-negative breast cancer spheroidsAires-Lopes, Beatriz, Coleborn, Elaina, Souza-Fonseca-Guimarães, Fernando and Ferreira-Halder, Carmen Veríssima (2025). Antitumor activity of violacein in osteosarcoma, neuroblastoma and triple-negative breast cancer spheroids. Toxicon, 265 108501. doi: 10.1016/j.toxicon.2025.108501 |
|
2025 Journal Article Lipoprotein Association Fluorometry (LAF) as a semi‐quantitative characterization tool to assess extracellular vesicle‐lipoprotein bindingGhebosu, Raluca, Goncalves, Jenifer Pendiuk, Fitri, Nur Indah, Iannotta, Dalila, Sharifpour, Mohammad Farouq, Coleborn, Elaina, Loukas, Alex, Souza‐Fonseca‐Guimaraes, Fernando and Wolfram, Joy (2025). Lipoprotein Association Fluorometry (LAF) as a semi‐quantitative characterization tool to assess extracellular vesicle‐lipoprotein binding. Journal of Extracellular Vesicles, 14 (10) e70172, e70172. doi: 10.1002/jev2.70172 |
|
2025 Journal Article Cancer-derived extracellular vesicles in natural killer cell immune evasion: molecular mechanisms and therapeutic insightsColeborn, Elaina, Ghebosu, Raluca, Wolfram, Joy and Souza-Fonseca-Guimaraes, Fernando (2025). Cancer-derived extracellular vesicles in natural killer cell immune evasion: molecular mechanisms and therapeutic insights. Molecular Therapy, 33 (9), 4113-4129. doi: 10.1016/j.ymthe.2025.05.038 |
|
2025 Journal Article Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunityWijesinghe, Sharanya K. M., Rausch, Lisa, Gabriel, Sarah S., Galletti, Giovanni, De Luca, Marco, Qin, Lei, Wen, Lifen, Tsui, Carlson, Man, Kevin, Heyden, Leonie, Mason, Teisha, Newland, Lewis D., Kueh, Andrew, Liao, Yang, Chisanga, David, Swatler, Julian, Voulaz, Emanuele, Marulli, Giuseppe, Errico, Valentina, Losurdo, Agnese, Rossi, Gustavo R., Souza-Fonseca-Guimaraes, Fernando, Huntington, Nicholas D., Gebhardt, Thomas, Utzschneider, Daniel T., Herold, Marco J., Shi, Wei, Schroeder, Jan, Lugli, Enrico and Kallies, Axel (2025). Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity. Nature Immunology, 26 (8), 1367-1383. doi: 10.1038/s41590-025-02219-2 |
|
2025 Journal Article Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsSek, Kevin, Chen, Amanda X. Y., Cole, Thomas, Armitage, Jesse D., Tong, Junming, Yap, Kah Min, Munoz, Isabelle, Dunbar, Phoebe A., Wu, Shiyi, van Elsas, Marit J., Hidajat, Olivia, Scheffler, Christina, Giuffrida, Lauren, Henderson, Melissa A., Meyran, Deborah, Souza-Fonseca-Guimaraes, Fernando, Nguyen, Dat, Huang, Yu-Kuan, de Menezes, Maria N., Derrick, Emily B., Chan, Cheok Weng, Todd, Kirsten L., Chan, Jack D., Li, Jasmine, Lai, Junyun, Petley, Emma V., Mardiana, Sherly, Bosco, Anthony, Waithman, Jason ... Beavis, Paul A. (2025). Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors. Nature Communications, 16 (1) 6123, 1-17. doi: 10.1038/s41467-025-59021-9 |
|
2025 Journal Article Highlights of 2024. Broadening anti‐cancer immunotherapy modalities with antibody–drug conjugates: emerging insights from clinical studiesJose, Jiya, Hooper, John D. and Souza‐Fonseca‐Guimaraes, Fernando (2025). Highlights of 2024. Broadening anti‐cancer immunotherapy modalities with antibody–drug conjugates: emerging insights from clinical studies. Immunology and Cell Biology, 103 (6), 530-534. doi: 10.1111/imcb.70017 |
|
2025 Journal Article Highlights of 2024: unleashing the power of NK cells—cancer's worst nightmareBourel, Capucine, Souza‐Fonseca‐Guimaraes, Fernando and Lesage, Sylvie (2025). Highlights of 2024: unleashing the power of NK cells—cancer's worst nightmare. Immunology and Cell Biology, 103 (6), 526-529. doi: 10.1111/imcb.70037 |
|
2025 Journal Article Highlights of 2024: Cytokines and ligands modulating NK cell effector functionsShajan, Aneena Mary, Alim, Louisa and Souza‐Fonseca‐Guimaraes, Fernando (2025). Highlights of 2024: Cytokines and ligands modulating NK cell effector functions. Immunology and Cell Biology, 103 (6), 522-525. doi: 10.1111/imcb.70014 |
|
2025 Journal Article Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CARLam, Pui Yeng, Omer, Natacha, Wong, Josh K. M., Tu, Cui, Alim, Louisa, Rossi, Gustavo R., Victorova, Maria, Tompkins, Hannah, Lin, Cheng-Yu, Mehdi, Ahmed M., Choo, Amos, Elliott, Melissa R., Coleborn, Elaina, Sun, Jane, Mercer, Timothy, Vittorio, Orazio, Dobson, Lachlan J., Mclellan, Alexander D., Brooks, Andrew, Tuong, Zewen Kelvin, Cheetham, Seth W., Nicholls, Wayne and Souza-Fonseca-Guimaraes, Fernando (2025). Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR. Clinical and Translational Medicine, 15 (1) e70140, 1-21. doi: 10.1002/ctm2.70140 |
|
2025 Journal Article Engineered iPSC‐derived natural killer cells: recent innovations in translational innate anti‐cancer immunotherapySun, Jane, Elliott, Melissa and Souza‐Fonseca‐Guimaraes, Fernando (2025). Engineered iPSC‐derived natural killer cells: recent innovations in translational innate anti‐cancer immunotherapy. Clinical and Translational Immunology, 14 (7) e70045, 1-15. doi: 10.1002/cti2.70045 |
